Impact of mitral stenosis on early and late outcomes of transcatheter aortic valve replacement for aortic stenosis: a single-center analysis.
Yoshiyuki YamashitaSerge SicouriAleksander DokollarMikiko SenzaiRoberto RodriguezEric M GnallPaul M CoadyHarish JarrettSandra V AbramsonKatie M HawthorneScott M GoldmanWilliam A GrayBasel RamlawiPublished in: The Journal of invasive cardiology (2024)
TAVR can be safely performed in patients with severe tricuspid aortic stenosis and concomitant MS, with early and mid-term outcomes comparable to those in patients without MS.
Keyphrases
- aortic stenosis
- transcatheter aortic valve replacement
- ejection fraction
- aortic valve replacement
- aortic valve
- transcatheter aortic valve implantation
- left ventricular
- mass spectrometry
- multiple sclerosis
- ms ms
- end stage renal disease
- coronary artery disease
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- mitral valve
- early onset
- patient reported outcomes
- insulin resistance
- weight loss